ADMA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ADMAAdma Biologics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ADMAAdma Biologics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ADMA 7

GRFSGrifols Worldwide Operationssupplier

—KEDPlasmaunlistedsupplier

—Areth, LLC ("Areth")unlistedsupplier

—Priority Healthcare Distributionunlistedcustomer

3 more · ADMA chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

ADMAAdma Biologics, Inc.

13.21▲+26.03%· post 13.24· delayed

Mkt cap$2.3BRevenue$141MQ3 FY26Revenue$510MFY25

AMGNAmgen Inc

461.49▼−3.55%· post 459.40· delayed

After hoursNov 5 '26delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

After hoursNov 5 '26delayed

ADMAAdma Biologics, Inc.

AMGNAmgen Inc

13.21▲+26.03%post 13.24delayed

Price

461.49▼−3.55%post 459.40delayed

$2.3B

Mkt cap

$258.8B

Q3 FY26$141M

Revenue

$10.4BQ3 FY26

FY25$510M

Revenue

$36.8BFY25

ADMA13.21▲+26.03%vsAMGN461.49▼−3.55%After hoursNov 5 '26delayed